(Reuters) – Drugmaker Endo International PLC on Thursday said it had agreed to pay $ 50 million to settle lawsuits from New York State and two of its largest counties related to the sale and marketing of opioids.
Endo stated that the settlement does not include any recognition of crime by Endo or its subsidiaries.
The settlement deters Endo from an ongoing lawsuit in New York prosecutors Letitia James and Suffolk and Nassau counties. Claims against AbbVie Inc. and Teva Pharmaceutical Industries remain.
The deal came after the country's three largest drug distributors – McKesson Corp., AmerisourceBergen and Cardinal Health – and Johnson & Johnson on Saturday said they would go ahead with a proposed $ 26 billion national deal to settle opioid cases against them.
Dublin-based Endo is not part of that deal.
"While disputes over the remaining opioid claims are ongoing, Endo is focused on its primary goal of reaching a global settlement, the company says." Endo is also currently exploring other strategic options and may seek to implement one or more of these options if not is possible to achieve a global solution. "
Hunter Shkolnik, a lawyer for Nassau County, said he was "glad our clients can be closed and it has kept Endo out of bankruptcy, it would have hurt everyone."
In July, Endo agreed to pay 35 million dollars to settle a lawsuit filed by Tennessee local governments and on behalf of a child allegedly addicted to drugs, to painkillers who accused the drugmaker of running the opioid epidemic.
New York prosecutor spokesman did not immediately respond to a Reuters request
Endo had removed its long-acting opioid analgesic from Opana ER from the market in July 201